Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0IW0
|
||||
Drug Name |
N-((cis)-4-(4-(dimethylamino)-6-methylpyrimidin-2-ylamino)cyclohexyl)-3,5-bis(trifluoromethyl)benzamide
|
||||
Synonyms |
CHEMBL583014
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H25F6N5O
|
||||
Canonical SMILES |
CN(C)c1cc(C)nc(N[C@@H]2CC[C@@H](CC2)NC(=O)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)n1
|
||||
InChI |
InChI=1S/C22H25F6N5O/c1-12-8-18(33(2)3)32-20(29-12)31-17-6-4-16(5-7-17)30-19(34)13-9-14(21(23,24)25)11-15(10-13)22(26,27)28/h8-11,16-17H,4-7H2,1-3H3,(H,30,34)(H,29,31,32)/t16-,17+
|
||||
InChIKey |
YHSRTUXPXLVIAG-CALCHBBNSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.